Astrocyte plasticity revealed by adaptations to severe proteotoxic stress (Q45167511)

10 December 2017

title

Astrocyte plasticity revealed by adaptations to severe proteotoxic stress (English)

1 reference

10 December 2017

0 references

Amanda M Titler

1 reference

10 December 2017

Jessica M Posimo

series ordinal

1 reference

10 December 2017

Rehana K Leak

series ordinal

1 reference

10 December 2017

publication date

19 February 2013

1 reference

10 December 2017

published in

Cell and Tissue Research

1 reference

10 December 2017

volume

352

1 reference

10 December 2017

1 reference

10 December 2017

page(s)

427-443

1 reference

Ischemic preconditioning in the aging heart: from bench to bedside

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Occurrence of the diffuse amyloid beta-protein (Abeta) deposits with numerous Abeta-containing glial cells in the cerebral cortex of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Effects of proteasome inhibitor, MG132, on proteasome activity and oxidative status of rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Neuroscience: Glia — more than just brain glue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

H2O2 preconditioning modulates phase II enzymes through p38 MAPK and PI3K/Akt activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Are synucleinopathies prion-like disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Protective role of heat shock proteins in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

The protective role of heme oxygenase-1 in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

The mystery and magic of glia: a perspective on their roles in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer's disease visual cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Oxidatively modified proteins in aging and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

A dual-hit animal model for age-related parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Regulation of proteasome-mediated protein degradation during oxidative stress and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Astrocytes: adaptive responses to low doses of neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Hormesis is central to toxicology, pharmacology and risk assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Progressive dopamine neuron loss in Parkinson's disease: the multiple hit hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Parkin deficiency increases the resistance of midbrain neurons and glia to mild proteasome inhibition: the role of autophagy and glutathione homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Preconditioning protects against oxidative injury involving hypoxia-inducible factor-1 and vascular endothelial growth factor in cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Developmental pesticide models of the Parkinson disease phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Ischemic tolerance and endogenous neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Metabolism and functions of glutathione in brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Hyperthermic preconditioning protects astrocytes from ischemia/reperfusion injury by up-regulation of HIF-1 alpha expression and binding activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

A synergistic role of hyperthermic and pharmacological preconditioning to protect astrocytes against ischemia/reperfusion injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Classification and basic pathology of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

21 January 2018

GFAP and astrogliosis

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Effects of small molecules on chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Gene-environment interactions: key to unraveling the mystery of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Antioxidant protection: A promising therapeutic intervention in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Hormetic responses in neural systems: consideration, contexts, and caveats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Haem oxygenase-1: non-canonical roles in physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Protein aggregation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

MG132, a proteasome inhibitor decreased the growth of Calu-6 lung cancer cells via apoptosis and GSH depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Cortical and striatal neurone number in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Oxidative stress and nitration in neurodegeneration: cause, effect, or association?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Recent advances in our understanding of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Oxidative stress in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Isoflurane preconditioning protects astrocytes from oxygen and glucose deprivation independent of innate cell sex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Methods to monitor chaperone-mediated autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Methods for monitoring autophagy from yeast to human

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

P2 Receptor Signaling in Neurons and Glial Cells of the Central Nervous System

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Chaperone signalling complexes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Assaying multiple biochemical variables from the same tissue sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Protein degradation by the ubiquitin-proteasome pathway in normal and disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Inhibition of MG132-induced mitochondrial dysfunction and cell death in PC12 cells by 3-morpholinosydnonimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Astrogliosis in the adult and developing CNS: is there a role for proinflammatory cytokines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Vitamin E paradox in Alzheimer's disease: it does not prevent loss of cognition and may even be detrimental.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Neuronal adenosine release, and not astrocytic ATP release, mediates feedback inhibition of excitatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Model fusion, the next phase in developing animal models for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Mechanisms of Disease: astrocytes in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glutathione--a review on its role and significance in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Proteolytic dysfunction in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Altered proteasomal function in sporadic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Protective roles for induction of autophagy in multiple proteinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

GFAP in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Timing is everything: making neurons versus glia in the developing cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glial fibrillary acidic protein and related glial proteins as biomarkers of neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glial cells in (patho)physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Back to the future with ubiquitin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Elevation of glutathione as a therapeutic strategy in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

The changing faces of glutathione, a cellular protagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Diazoxide pretreatment induces delayed preconditioning in astrocytes against oxygen glucose deprivation and hydrogen peroxide-induced toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

S100B in brain damage and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Influence of age on stroke and preconditioning-induced ischemic tolerance in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Heme oxygenase-1: role in brain aging and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Neural heme oxygenase-1 expression in idiopathic Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Heme oxygenase-1 and neurodegeneration: expanding frontiers of engagement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

S100B in neuropathologic states: the CRP of the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

21 January 2018

Plasticity of astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Regulation of survival gene hsp70.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Morphometric analysis of the prefrontal cortex in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Reactive astrocytes give neurons less support: implications for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

S100B protein in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Rescue from a two hit, high-throughput model of neurodegeneration with N-acetyl cysteine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Intrinsic disorder in proteins associated with neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Differential metabolic adaptation to acute and long-term hypoxia in rat primary cortical astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

21 January 2018

Inducible proteopathies

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Etiopathogenesis of Parkinson disease: a new beginning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Hsp70 molecular chaperones and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Ischemic preconditioning: the role of mitochondria and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Integration of Clearance Mechanisms: The Proteasome and Autophagy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

A central role of heme oxygenase-1 in cardiovascular protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Dual role of 3-methyladenine in modulation of autophagy via different temporal patterns of inhibition on class I and III phosphoinositide 3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Autophagy in the Central Nervous System: Implications for Neurodegenerative Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Hypoxic preconditioning increases iron transport rate in astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Microtubule-associated tau protein positive neuronal and glial inclusions in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Tau protein aggregation in the frontal and entorhinal cortices as a function of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Glutathione and Parkinson's disease: is this the elephant in the room?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

Alzheimer disease, the two-hit hypothesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1571-4

10.1007/S00441-013-1571-4

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1034818754

0 references

1 reference